Dimensional Fund Advisors LP Intellia Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,447,250 shares of NTLA stock, worth $21.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,447,250

Previous 1,324,561 9.26%

Holding current value

$21.4 Million

Previous $29.6 Million 0.33%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$19.72 - $27.36 $2.42 Million - $3.36 Million	122,689 Added 9.26%	1,447,250 $29.7 Million
Q2 2024 Aug 09, 2024	BUY	$20.02 - $27.22 $1.98 Million - $2.69 Million	98,865 Added 8.07%	1,324,561 $29.6 Million
Q1 2024 May 10, 2024	BUY	$23.82 - $32.8 $1.31 Million - $1.8 Million	54,867 Added 4.69%	1,225,696 $33.7 Million
Q4 2023 Feb 07, 2024	BUY	$23.16 - $32.34 $1.41 Million - $1.96 Million	60,748 Added 5.47%	1,170,829 $35.7 Million
Q3 2023 Nov 09, 2023	BUY	$31.62 - $45.78 $2.65 Million - $3.84 Million	83,840 Added 8.17%	1,110,081 $35.1 Million
Q2 2023 Aug 09, 2023	BUY	$34.58 - $46.03 $7.11 Million - $9.47 Million	205,749 Added 25.08%	1,026,241 $41.9 Million
Q1 2023 May 12, 2023	SELL	$33.3 - $44.82 $3.32 Million - $4.46 Million	-99,584 Reduced 10.82%	820,492 $30.6 Million
Q4 2022 Feb 09, 2023	BUY	$33.21 - $62.69 $331,037 - $624,893	9,968 Added 1.1%	920,076 $32.1 Million
Q3 2022 Nov 10, 2022	SELL	$53.92 - $71.7 $473,956 - $630,243	-8,790 Reduced 0.96%	910,108 $50.9 Million
Q2 2022 Aug 12, 2022	SELL	$38.49 - $76.21 $1.03 Million - $2.05 Million	-26,849 Reduced 2.84%	918,898 $47.6 Million
Q1 2022 May 13, 2022	SELL	$58.27 - $118.99 $6.51 Million - $13.3 Million	-111,663 Reduced 10.56%	945,747 $68.7 Million
Q4 2021 Feb 09, 2022	SELL	$100.76 - $138.36 $8.4 Million - $11.5 Million	-83,348 Reduced 7.31%	1,057,410 $125 Million
Q3 2021 Nov 12, 2021	BUY	$132.37 - $176.78 $57,845 - $77,252	437 Added 0.04%	1,140,758 $153 Million
Q2 2021 Aug 12, 2021	BUY	$60.88 - $161.91 $9.23 Million - $24.5 Million	151,568 Added 15.33%	1,140,321 $185 Million
Q1 2021 May 14, 2021	BUY	$46.59 - $83.68 $199,405 - $358,150	4,280 Added 0.43%	988,753 $79.3 Million
Q4 2020 Feb 25, 2021	BUY	$18.83 - $63.53 $18.5 Million - $62.5 Million	984,473 New	984,473 $53.6 Million

Others Institutions Holding NTLA

# of Institutions

315

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.12B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Intellia Therapeutics, Inc. Transaction History